TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CE

CE

Celanese Corp

Next earnings Jul 16, 2026 (after close) · consensus $2.25 EPS, $2.85B rev

Last earnings +0.4% on 2026-05-05

Sell
$47.68
▲ +3.81%
$47.68▼ -15.82%
over 1Y
L $35.49H $69.24
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.8%
1W-2.5%
1M-13.7%
3M-25.5%
YTD+13.2%
1Y-15.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 26 analysts
Buy

A deeply levered chemicals company with two straight years of billion-dollar losses and a gutted dividend — recovery is a bet, not a base case.

Revenue (FY2025) $9.54B · FY2025

Celanese is a specialty/commodity chemicals producer (acetyls and engineered materials) caught in a severe down-cycle and weighed down by the debt-funded Mobility & Materials acquisition from DuPont. FY2025 was the second consecutive ugly year: revenue fell 7.1% to $9.54B, gross margin compressed to 20.5%, the operating line swung to a -$786M loss, and the company posted a $1.17B net loss (after a $1.54B loss in FY2024). Diluted EPS was -$10.64. The losses are heavily driven by goodwill/intangible impairments — the 10-K flags 'additional impairment of goodwill or intangible assets' as an ongoing risk — but the underlying demand picture is genuinely weak across CE's cyclical end-markets (automotive, electronics, construction, textiles).

The balance sheet is the crux. Long-term debt stands at $12.6B against just $4.05B of equity (which fell 21.1%), with $1.2B of current debt maturities. Management's response tells the story: the dividend was slashed 95.8% (to just $13M) to conserve cash for deleveraging. The 10-K repeatedly warns that the company's 'level of indebtedness... could diminish our ability to raise additional capital,' limit strategic flexibility, raise interest expense and pressure credit ratings via further downgrades. That is a balance sheet operating with little margin for error.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:59 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$8.54B$9.67B$10.9B$10.3B$9.54B
Gross profit$2.68B$2.38B$2.58B$2.34B$1.95B
Operating income$1.95B$1.38B$1.67B-$720M-$786M
Net income$1.89B$1.89B$1.94B-$1.54B-$1.17B
Diluted EPS$16.86$17.34$17.76-$14.11-$10.64
Net margin22.1%19.6%17.8%-15.0%-12.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$17.8B
EV / EBITDA—
EV / Sales1.9
EV / FCF22.1
P / FCF6.5
PEG (trailing)—
Earnings yield-22.3%
FCF yield15.4%

Quality & risk

ROIC (est.)-3.5%
Free cash flow$803M
Total debt$13.8B
Net cash-$12.6B
Piotroski F-Score4/9

Capital returns

Buyback yield0.0%
Dividend yield (est.)0.2%
Shareholder yield0.2%
Shares Δ YoY+0.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Other event2026-06-10
  2. 10-Q Quarterly report2026-05-06
  3. 8-K Reg FD disclosure2026-05-05
  4. 8-K Earnings results2026-05-05
  5. 8-K Officer / director change2026-04-20
  6. 8-K Shareholder vote2026-04-17
  7. 8-K Officer / director change2026-03-04
  8. DEF 14A Proxy statement2026-03-04
  9. 10-K Annual report2026-02-24

Recent filings

all on EDGAR ↗
25-NSEFiling2026-06-25open ↗11-KPeriod ending 2025-12-312026-06-22open ↗8-KPeriod ending 2026-06-102026-06-10open ↗SDFiling2026-05-29open ↗SCHEDULE 13G/AFiling2026-05-14open ↗4Period ending 2026-05-112026-05-13open ↗4Period ending 2026-05-112026-05-13open ↗4Period ending 2026-05-092026-05-13open ↗4Period ending 2026-05-112026-05-13open ↗4Period ending 2026-05-092026-05-13open ↗4Period ending 2026-05-092026-05-13open ↗4Period ending 2026-05-112026-05-13open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthC+
ProfitabilityF
Financial healthC
MomentumD
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
35.4952-week69.24
Revenue
$9.54B
-7.1% YoY
Net margin
-12.2%
ROE
-28.8%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$9.54B-7.1%
Net income-$1.17B+24.4%
Gross profit$1.95B-16.4%
Operating income-$786M-9.2%
Diluted EPS-$10.64+24.6%
Cash & equivalents$1.26B+31.3%
Total assets$21.7B-5.0%
Stockholders' equity$4.05B-21.1%
Gross: 20.5%Op.: -8.2%

Frequently asked

Is Celanese Corp (CE) a buy?
CE currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. A deeply levered chemicals company with two straight years of billion-dollar losses and a gutted dividend — recovery is a bet, not a base case.
What is Celanese Corp's quality score?
CE scores 54.14670337873805/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001306830, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/21/2026, 8:59:45 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-11
Chinn Bruce E.
Director
Award2.98K
2026-05-11
Noonan Anne P
Director
Award2.98K
2026-05-11
Koenig Michael
Director
Award2.98K
2026-05-11
MOORTHY GANESH
Director
Award2.98K
2026-05-11
Kissire Deborah J.
Director
Award2.98K
2026-05-11
Rucker Kim K.W.
Director
Award2.98K
2026-05-11
Hill Kathryn
Director
Award2.98K
2026-05-11
Kuehn Christopher J
Director
Award2.98K
2026-05-09
Koenig Michael
Director
Tax1.01K @ $57.51$58.3K
2026-05-09
Kissire Deborah J.
Director
Disposed (D)3.38K
2026-05-09
Rucker Kim K.W.
Director
Disposed (D)3.38K
2026-05-09
Kuehn Christopher J
Director
Disposed (D)3.38K

Dividends

Quarterly
Yield (TTM)
0.3%
Annual / share
$0.12
Last ex-date
2026-04-27
Last amount
$0.03
ex 2026-04-27paid 2026-05-11$0.03
ex 2026-02-24paid 2026-03-10$0.03
ex 2025-10-28paid 2025-11-12$0.03
ex 2025-07-29paid 2025-08-11$0.03
ex 2025-04-28paid 2025-05-12$0.03
ex 2025-02-25paid 2025-03-11$0.03

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-05Miss -4.6% est▲ +0.39%8-K ↗
2026-02-17Miss -28.6% est▼ -5.28%8-K ↗
2025-11-06Beat +6.6% est▼ -2.25%8-K ↗
2025-08-11Miss -0.1% est▼ -1.31%8-K ↗
2025-05-05—▼ -2.57%8-K ↗
2025-02-18—▲ +2.72%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2022-09-14Kathy ManningSell$1.00K–$15.0KPTR ↗
2022-08-10Kathy ManningBuy$1.00K–$15.0KPTR ↗
2022-04-25Dwight EvansSell$1.00K–$15.0KPTR ↗
2022-04-19John RutherfordSell$15.0K–$50.0KPTR ↗
2021-07-09Dwight EvansBuy$1.00K–$15.0KPTR ↗
2018-02-15Thomas J. RooneyBuy$1.00K–$15.0KPTR ↗
2017-11-13Thomas J. RooneySell$1.00K–$15.0KPTR ↗
2017-08-10Thomas J. RooneySell$1.00K–$15.0KPTR ↗
2017-07-14Thomas J. RooneyBuy$15.0K–$50.0KPTR ↗
2017-06-14Thomas J. RooneySell$1.00K–$15.0KPTR ↗
2017-01-24Thomas J. RooneyBuy$1.00K–$15.0KPTR ↗
2017-01-16Thomas J. RooneyBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Celanese to Hold Second Quarter Earnings Conference Call on August 5, 2026Bullish
finance.yahoo.com· 2026-06-25
What Offers Celanese Corporation (CE) the Edge of Advantage?Bullish
finance.yahoo.com· 2026-06-18
Celanese Teams Up With Siegwerk to Advance Printing Ink SolutionsBullish
finance.yahoo.com· 2026-06-17
Celanese and Siegwerk Collaborate to Advance More Sustainable Printing Ink Solutions with Bio-Based Ethyl AcetateBullish
finance.yahoo.com· 2026-06-15
Celanese Expands Automotive Reach as Aisan Chooses CO2-Based POMBullish
finance.yahoo.com· 2026-06-09
Is Dow Stock Outperforming the Dow?Bullish
finance.yahoo.com· 2026-06-09

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score54 vs 67
Revenue growth-7.1% vs 7.5%
Net margin-12.2% vs 10.0%
Return on equity-28.8% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 19d
Bullish
+0.16
vs typical · 31 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.